Neoantigenic properties of TP53 variants modify cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher, Claire Freyçon, D B Collantes Hoyos, Sandrine Blanchet, Murielle Verboom, Christina M. Dutzmann, Sophie Coutant, Jacqueline Bou, Bertrand Fin, Robert Olaso, Jean‐François Deleuze, Thierry Frébourg, Benjamin D. Greenbaum, , Pierre L. Hainaut
The paper analyzes how neoantigenic properties of TP53 variants correlate with cancer risk and presentation in Li-Fraumeni syndrome carriers.
EBioMedicine · Dec 9, 2025Peer-reviewedGenetic & Genomic Medicine